152 related articles for article (PubMed ID: 37016353)
1. Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.
Afzaljavan F; Vahednia E; Barati Bagherabad M; Vakili F; Moezzi A; Hosseini A; Homaei Shandiz F; Kooshyar MM; Nassiri M; Pasdar A
BMC Med Genomics; 2023 Apr; 16(1):72. PubMed ID: 37016353
[TBL] [Abstract][Full Text] [Related]
2. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
[TBL] [Abstract][Full Text] [Related]
3. Association of caspase 8 promoter variants and haplotypes with the risk of breast cancer and its molecular profile in an Iranian population: A case-control study.
Bagherabad MB; Afzaljavan F; Vahednia E; Rivandi M; Vakili F; Sadr SSH; Shandiz FH; Pasdar A
J Cell Biochem; 2019 Oct; 120(10):16435-16444. PubMed ID: 31257627
[TBL] [Abstract][Full Text] [Related]
4. Fine-mapping CASP8 risk variants in breast cancer.
Camp NJ; Parry M; Knight S; Abo R; Elliott G; Rigas SH; Balasubramanian SP; Reed MW; McBurney H; Latif A; Newman WG; Cannon-Albright LA; Evans DG; Cox A
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):176-81. PubMed ID: 22056502
[TBL] [Abstract][Full Text] [Related]
5. A breast cancer risk haplotype in the caspase-8 gene.
Shephard ND; Abo R; Rigas SH; Frank B; Lin WY; Brock IW; Shippen A; Balasubramanian SP; Reed MW; Bartram CR; Meindl A; Schmutzler RK; Engel C; Burwinkel B; Cannon-Albright LA; Allen-Brady K; Camp NJ; Cox A
Cancer Res; 2009 Apr; 69(7):2724-8. PubMed ID: 19318553
[TBL] [Abstract][Full Text] [Related]
6. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
8. Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population.
Srivastava K; Srivastava A; Mittal B
Mol Carcinog; 2010 Jul; 49(7):684-92. PubMed ID: 20564345
[TBL] [Abstract][Full Text] [Related]
9. Association of Caspase-8 Genotypes With Oral Cancer Risk in Taiwan.
Shih LC; Tsai CW; Sun KT; Hsu HM; Shen TC; Tsai YT; Chang WS; Lin ML; Wang YC; Gong CL; Bau DT
In Vivo; 2019; 33(4):1151-1156. PubMed ID: 31280204
[TBL] [Abstract][Full Text] [Related]
10. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
11. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
12. Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
Ramezani S; Sharafshah A; Mirzanejad L; Hadavi M
Gene; 2019 Sep; 712():143954. PubMed ID: 31288058
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
Barati F; Bahari G; Asadi A; Nakhaee A; Hashemi SM; Taheri M; Hashemi M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4339-4346. PubMed ID: 36580018
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
[TBL] [Abstract][Full Text] [Related]
15. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
17. The Apoptosis Pathway and CASP8 Variants Conferring Risk for Acute and Overuse Musculoskeletal Injuries.
Seale K; Burger M; Posthumus M; Häger CK; Stattin E; Nilsson KG; Collins M; September AV
J Orthop Res; 2020 Mar; 38(3):680-688. PubMed ID: 31692049
[TBL] [Abstract][Full Text] [Related]
18. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
19. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
20. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
